← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2010First marketed drug
Aug 7, 2020First NDA
Aug 7, 2020Last known activity
Aug 7, 2020
Timeline
2000s
- Jan 1, 2007
Trevena Inc.— Founded
2020s
- Aug 7, 2020
oliceridine— Marketing Organization
- Aug 7, 2020
oliceridine— NDA Organization
- Aug 7, 2020
oliceridine— NDA Secondary Org
Drugs by trial phase (9 distinct, 16 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (27)
- NCT04201080Lead sponsorPhase 1Nov 5, 2019
- NCT02815709Lead sponsorPhase 3May 1, 2016
- NCT02815709Study directorPhase 3May 1, 2016
- NCT02820324Lead sponsorPhase 3May 1, 2016
- NCT02820324Study directorPhase 3May 1, 2016
- NCT02656875Study chairPhase 3Dec 1, 2015
- NCT02656875Lead sponsorPhase 3Dec 1, 2015
- NCT02520297Lead sponsorPhase 2Sep 1, 2015
- NCT02411500Lead sponsorPhase 1Feb 1, 2015
- NCT02335294Lead sponsorPhase 2Dec 1, 2014
- NCT02344303Lead sponsorPhase 1Dec 1, 2014
- NCT02344303Study directorPhase 1Dec 1, 2014
- NCT02211625Lead sponsorPhase 1Jul 1, 2014
- NCT02211625Study directorPhase 1Jul 1, 2014
- NCT02169934Study directorPhase 1Jun 1, 2014
Details
- Founded
- Chesterbrook, PA, US Jan 1, 2007
- First NDA
- Aug 7, 2020
- Last known activity
- Aug 7, 2020
Designations held
- Fast track